Vol 26, No 12 (2024): Коморбидность в клинике внутренних болезней
- Year: 2024
- Published: 18.12.2024
- Articles: 13
- URL: https://consilium.orscience.ru/2075-1753/issue/view/9493
Full Issue
Articles
Some molecular-genetic determinants of premature aging in women
Abstract
Background. Accelerated biological aging is associated with age-related diseases and an increased risk of mortality. Genetic predisposition may be an important factor in this process.
Aim. To determine the significance of genetic polymorphisms in the VDR and COL1A1 genes in accelerated aging.
Materials and methods. The study included 100 women aged 20–35 years, divided into groups with accelerated (Group 1) and normal/slow (Group 2) aging rates. We assessed biological age using V.P. Voytenko's formula. Genetic polymorphisms analyzed were: VDR 283 A>G (Bsml), VDR 2 A>G (Fokl), COL1A1 1546 G>T, COL1A1 -1997 C>A.
Results. The VDR 283 A>G (AA) polymorphism was associated with accelerated aging, occurring more frequently in Group 1 (18% vs 4% in Group 2, p=0.025). The COL1A1 -1997 C>A polymorphism was more prevalent in Group 2 (76% vs 56% in Group 1, p=0.035). A multifactorial model identified combinations of polymorphisms that predict accelerated or slow aging with an accuracy of 0.72.
Conclusion. Genetic predisposition plays a significant role in accelerated aging. Analysis of VDR and COL1A1 polymorphisms can help identify the risk of premature aging and may serve as a basis for further research and the development of new approaches to prevent age-related diseases.



Oral glucose-lowering drugs and long-term risk of benign prostatic hyperplasia
Abstract
Background. One of the most prominent threats for masculine health is comorbidity between benign prostatic hyperplasia (BPH) and diabetes mellitus type 2. Many publications suppose influence of hyperglycemia on lower urinary tract obstruction. Question about influence of the most common oral glucose-lowering drugs – biguanides (metformin hydrochloride) and third-generation sulfonylurea (glimepiride) has not been answered yet.
Aim. To assess whether glucose-lowering drugs affect risk of benign prostatic hyperplasia (BPH) in men with type 2 diabetes who initiated first-line treatment with either metformin or sulfonylurea monotherapy from 2012 until 2022 in the National Medical Research Center for Endocrinology.
Materials and methods. Single centre, retrospective, comparative study. Retrospective analysis of in-/outpatient medical cards. Primary outcome measures: Rates of subsequent BPH, identified based on community prescriptions for BPH-related treatment or hospital BPH diagnoses, and rates of transurethral resection of the prostate (TURP). Rates in metformin hydrochloride and sulfonylurea users were compared overall and stratified by 6-month haemoglobin A1c (HbA1c) using Cox regression.
Results. In 95 metformin initiators with a median follow-up of 10 years, the 10-year cumulative BPH incidence was 25.7% (25 cases; 95% CI 24.2–27.1). Compared with 95 sulfonylurea users [median follow-up 8 years, 10-year cumulative incidence 27.4% (17 cases; 95% CI 16.2–18.6)], the crude HR for BPH was 0.83 (95% CI 0.77–0.89) and adjusted HR in the ITT analyses was 0.97 (95% CI 0.88–1.06). For TURP, the adjusted HR was 0.96 (95% CI 0.63–1.46). In the as-treated analysis, adjusted HR for BPH was 0.91 (95% CI 0.81–1.02).
Conclusion. Compared with sulfonylurea, metformin did not substantially reduce the incidence of BPH in men with diabetes.



RUSS-AGE study: Markers of carbohydrate metabolism and their time course in different age groups of a healthy population of the Russian Federation
Abstract
Background. One of the important tasks of modern science is to search for key biomarkers of aging of various body systems. Parameters of carbohydrate metabolism play an essential role in maintaining vital activity. The prevalence of carbohydrate metabolism disorders increases with age, but the time course of changes in individual markers remains poorly understood. Therefore, it is important to investigate the patterns of changes in carbohydrate metabolism markers in different age groups among healthy participants, which is the objective of the RUSS-AGE study.
Aim. To evaluate changes in carbohydrate status markers (adiponectin, leptin, glucose, glycated hemoglobin, insulin, and carboxymethyllysine – CML) in different age groups of a healthy Russian population.
Materials and methods. The study was conducted at the Pirogov Russian National Research Medical University in collaboration with the Moscow City Outpatient Clinic No. 220. The study group included subjects 18 years of age and older who signed an informed consent form; the exclusion criteria were current acute disease, exacerbation of a chronic disease, surgical intervention within the last month, and moderate to severe chronic age-associated diseases. Blood samples were taken to measure aging markers: glucose (enzymatic ultraviolet method), insulin (chemiluminescent enzyme immunoassay), glycated hemoglobin (calorimetric method), CML, adiponectin, and leptin (enzyme immunoassay). The study was approved by the local ethics committee (Minutes No. 59 dated 13.09.2022). Statistical analysis was carried out using the R programming language version 4.4.0. The significance threshold for the p-value values given in the article is 0.05.
Results. The study included 711 participants, which were divided into eight age groups. According to the intergroup comparison, a statistically significant direct relationship of age with adiponectin (p<0.001), glucose (p<0.001), and glycated hemoglobin (p<0.001) was found. No significant correlation with age was found for leptin (p=0.116), insulin (p=0.078), and CML (p=0.506). After conducting a statistical analysis using linear regression to assess the dependence of variables on age, it was found that only adiponectin, glucose, and glycated hemoglobin significantly increase with age (p<0.001).
Conclusion. The study showed a significant increase in adiponectin, glucose, and glycated hemoglobin, while leptin, insulin and CML had no significant correlation with age.



Follow up of clinical outcomes in type 1 diabetic patients according to the results of dynamic examination in the mobile center "Diamobil"
Abstract
Background. Type 1 diabetes mellitus (T1DM) is a severe disease associated with reduced life expectancy. Understanding the causes and methods of reducing risks for this cohort is highly relevant for developing measures to reduce the number of years lost.
Aim. To assess clinical outcomes: the frequency of diabetic complications, structure of mortality among T1DM patients who were examined at dynamic examination in the mobile center "Diamobil" in the Arkhangelsk region in 2005 and 2023.
Materials and methods. The study was conducted on a cohort of patients with T1DM, examined at "Diamobil" in Arkhangelsk region in 2005 (n=319), with dynamic follow up of vital and clinical status, clinical parameters and frequency of complications over an 18-year period. At 2023, out of 319 people in the primary cohort – 61 patients died, 206 were in "alive" status and 52 were removed from analysis. Statistical analysis is performed with the help of Statistics v.13.3.
Results. In the dynamic cohort (n=206) at 2023 median age of patients was 40 years [34; 55], duration of DM – 28 years [24; 33], percentage of women – 55%. Compared to 2005, glycated hemoglobin was comparable, there were an increase in body mass index (21.9 kg/m2 vs 25.1 kg/m2) and obesity rate from 3.1 to 11.2% (p=0.006), a decrease in estimated glomerular filtration rate (103.1 ml/min/1.73 mm2 vs 86.4 ml/min/1.73 mm2; p<0.001) and increased frequency of diabetic complications: chronic kidney disease (CKD) any stage from 24.9 to 69.4%, Stage 3a CKD from 0.5 to 7.4% (p=0.003), diabetic retinopathy from 26.4 to 74.6%, diabetic neuropathy from 25.9 to 78.2% (p<0.001), which reflects the long-term effect of the hyperglycemia factor. Based on the results of the analysis of mortality structure by proximal cause, it was established that the most frequent causes of death were cardiovascular disease – myocardial infarction, acute cerebral circulation disorder, heart failure and other cardiovascular diseases – 42.6%; death due to hypoglycemic and ketoacidotic coma – 3.2%, terminal cardiovascular disease – 14.8%. Deceased patients were characterized by a longer duration of DM (13 years vs 8 years), higher glycated hemoglobin (9.4% vs 8.4%), lipid profile (total cholesterol 4.77 mmol/l vs 4.41 mmol/l; TG 1.31 mmol/l vs 0.98 mmol/l) and albuminuria (70 mg/mmol vs 6 mg/mmol; p<0.001).
Conclusion. "Diamobil" control epidemiological studies can be positioned as the optimal method of risk cohort survey coverage for the assessment of dynamic indicators in real clinical practice.



Nutritional support as a way to adjust the body's immune response: Experimental data and clinical studies. A review
Abstract
According to the World Health Organization, 2 billion people all over the world suffer from infectious diseases every year. Infectious diseases remain among the leading causes of death and the first cause of premature death despite the implementation of vaccination programs. Vitamins and micronutrients are essential in supporting both the cellular and humoral parts of the immune system (IS), increasing resistance to infections. Micronutrient deficiency is a recognized global public health problem, and hypovitaminosis and nutrient deficiency conditions predispose to infections. Micronutrients such as vitamins A, C, D, E, B2, B6, B12, folic acid, selenium, zinc, and iron are necessary to maintain immunocompetency. Both in adulthood and in old age, patients have an increased risk of occurrence and severity of infections due to the high prevalence of hypovitaminosis, a decrease in the function of the IS, and the presence of comorbidities. Nutritional support by vitamin and mineral complexes (VMC) with rational composition is a strategy to correct the immune response. VMCs should complement a healthy diet and contain micronutrients within the recommended amounts at the level of daily food requirement. It is advisable to use a differentiated approach to VMCs to modulate the IS function. Basic nutritional support with vitamins C, D, and zinc is most often sufficient for people without the risks of severe and complicated acute respiratory infections. Various mechanisms of action and different targets of micronutrients that correct the body's immune response and synergistic interactions support the discussion of the hypothesis of a more pronounced effect of multicomponent VMCs. In the presence of chronic diseases, in the case of comorbidity, it is advisable to use expanded formulation VMCs containing, in addition to vitamins C, D, and zinc, other micronutrients, such as vitamins A, E, B, copper, selenium, which helps reduce the risk of severe course and complications of respiratory infections in at-risk groups.



Effectiveness of an innovative oral hygiene product in patients with obesity and type 2 diabetes mellitus in regulating appetite and food preferences
Abstract
Background. Diabetes mellitus (DM) and obesity are diseases that lead to systemic complications that shorten life expectancy and reduce quality of life. Treatment and control of these diseases can reduce the risk of complications. However, existing lifestyle change programs and drug therapy have limited effectiveness, and therefore, the search for new methods of treating diabetes and obesity is still relevant.
Aim. To determine the effectiveness of an oral care product (OCP) containing curcumin, thyme, and catechins in patients with obesity and type 2 DM (T2DM) in reducing appetite, changing taste preferences, and improving oral hygiene.
Materials and methods. The study patients were divided into three groups: those with obesity and T2DM, those with obesity without T2DM, and a control group of persons without obesity and carbohydrate metabolism disorders. All participants were recommended to irrigate the oral cavity 3 times a day for 20–30 with an OCP containing 0.25% curcumin, 0.05% thyme, and 0.05% catechins 30 minutes before meals for 30 days. Initially and after a month of daily use of the OCP, food preferences were assessed based on the NHANES Food Questioner and the oral cavity condition.
Results. The study included 67 patients. According to the questionnaire, the consumption of the following products decreased in all three groups of subjects: red meat, sausages, fast food, cookies, tomato juice, beer, red wine, and butter. Hyperemia, edema, ulcerative defects, and oral dryness decreased in obese patients with and without T2DM.
Conclusion. OCP use decreased appetite and changed taste preferences and also significantly improved the condition of the oral mucosa and gums in obese patients with and without T2DM. Further studies are needed to assess the therapeutic potential of OCP with curcumin, thyme, and catechins in treating obesity and carbohydrate metabolism disorders.



Real-world effectiveness of remote monitoring of the international normalized ratio in patients undergoing heart valve replacement using the CoaguChek® INRange system with a remote data transmission module
Abstract
Background. Systems for self-determination of international normalized ratio (INR) may increase adherence to regular monitoring of hemostasis parameters in patients taking vitamin K antagonists. However, evidence of the effectiveness of self-determination of INR in real-world clinical practice in Russia is limited.
Aim. To compare the effectiveness of remote monitoring of INR using the CoaguChek® INRange coagulometer in patients who have undergone mechanical heart valve implantation with traditional INR control by measuring it in the outpatient department laboratory.
Materials and methods. A prospective study enrolled 101 patients receiving warfarin after a mitral or aortic mechanical heart valve prosthesis implantation. In Group 1 (n=51), conventional laboratory INR control was used; in Group 2 (n=50), patients monitored INR by themselves using a CoaguChek® INRange coagulometer. The follow-up duration was 1 year.
Results. Patients in Groups 1 and 2 did not differ in INR: 2.62 [2.45; 2.85] vs 2.6 [2.5; 2.8], respectively (data are presented as the median [1st to 3rd quartile]), and the time of INR in the therapeutic range: 66.7% [50; 78.6] vs 67.7% [53.2; 80.6]. The intervals between INR determinations in Group 1 were significantly longer: 30.5 [29.5; 31] days vs 20 [13; 25] days.
Conclusion. The CoaguChek® INRange system enables remote patient monitoring during continuous warfarin therapy and achievement of the target INR with a time in the therapeutic range comparable to that for patients with INR measurements in outpatient laboratories.



Dynamics of uric acid concentration against the background of early dapagliflozin use in patients with acute decompensation of heart failure
Abstract
Background. Acute decompensation of heart failure (ADHF) is an urgent problem of modern cardiology due to unfavourable prognosis and high frequency of repeated hospitalizations. The risk of acute kidney injury in patients with ADHF, which significantly worsens clinical outcomes, is high, including due to elevated uric acid levels.
Aim. To evaluate the effect of sodium-glucose cotransporter type 2 inhibitor dapagliflozin in patients with ADHF with reduced left ventricular ejection fraction (LVEF) on uric acid levels.
Materials and methods. The study included 122 patients with ADHF and reduced LVEF (28±6%), III FC 97 (79.5%) patients and II FC 25 (20.5%). All patients received therapy for ADHF according to available guidelines. Patients were divided into two groups: the first group standard therapy, patients in the second group were added dapagliflozin at a dose of 10 mg to standard therapy. Dapagliflozin was administered on average on the 2nd day (1–3) from admission to the hospital on condition of stable haemodynamics. The duration of follow-up was 6 months. The level of uric acid, creatinine, glomerular filtration rate, NT-proBNP, CRP and ST2 at the time of inclusion in the study and 6 months after hospital discharge were analysed.
Results. In patients with ADHF and reduced LVEF, a uric acid level equal to or greater than 667.9 μmol/L during hospitalisation predicted a high risk of death during the 6-month follow-up period. Decrease of uric acid level was observed only on the background of dapagliflozin therapy 472 (366–594) μmol/L initially, 326 (275–419) μmol/L when ADHF compensation was achieved (p<0.001), after 6 months the significant changes remained – 359 (263–410) μmol/L (p<0.001). Against the background of dapagliflozin therapy there was a significant decrease in NT-proBNP level after 6 months from 2059 pg/ml (1456–4204.5) to 1101 pg/ml (415.8–3371.5); p<0.006; decrease in ST2 concentration after 6 months from 24. 4 ng/ml (15.1–35) to 19.4 ng/ml (13.3–30.1); p<0.041; decrease in SRP after six months from 2.9 mg/L (1.2–7.1) to 2.1 mg/L (0.9–2.8); p<0.015; no worsening of renal function was noted.
Conclusion. It can be concluded that dapagliflozin has a favourable safety and efficacy profile when used in patients with ADHF and hyperuricemia.



Retrospective analysis of the causes of uveitis in patients of the ophthalmology department of a multidisciplinary clinic: the place of hyperuricemia
Abstract
Background. Prolonged, including asymptomatic hyperuricemia (HU) for 7–10 years leads to the formation of sodium monourate deposits in various organs and tissues.
Aim. To study the incidence of noninfectious uveitis (NU) caused by HU.
Materials and methods. A retrospective evaluation of medical records of 217 patients diagnosed with NU in the ophthalmologic department of the general clinic for 10 years was carried out. Inclusion criteria: excess of serum uric acid values beyond the reference value (464 μmol/L), absence of other reasons explaining uveitis in the medical history. Exclusion criteria: glaucoma, recurrence of uveitis, pathology of ENT organs and oral cavity. Data are presented as median and interquartile range. Spearman's rank correlation coefficient was used as a criterion to assess the relationship between quantitative variables. The threshold level of statistical significance was taken as 0.05.
Results. There were 19 patients, mean age of men – 60 years (54–69 years), mean age of women – 60 years (37–67 years), leukocyte count – 7.8×109 (6.4–9.4×109), SOE – 52.5 mm/h (47–61 mm/h), CRP – 62.6 mg/L (53–68.1 mg/L), MC – 560 μmol/L (531–601 μmol/L). Among the concomitant pathology: cataract was detected in 8 patients (44.4% of the total), hypertension – in 7 (38.9%) patients, CHD in its various forms – in 6 patients (33.3%), chronic obstructive pulmonary disease and bronchial asthma – in 2 (11.1%) patients, diabetes mellitus – in 1 (5.3%) patient, gout – in 2 (11.1%) patients, and urolithiasis – in 4 (21%) patients. Statistically significant direct correlations were found between uric acid levels with COE (ρ=0.993; p<0001), CRP (ρ=0.998; p<0001). All identified correlations had strong closeness according to the Cheddock scale.
Conclusion. Despite the low incidence of HU-induced NU, examination of serum urate levels is an important diagnostic criterion in recognizing the cause of uveitis.



The use of pleiotropic effects of some gastroenterological drugs in the treatment of patients with non-alcoholic fatty liver disease and cardiovascular diseases: A review
Abstract
The main task of modern medicine is to reduce mortality from cardiovascular diseases. It can be achieved, first of all, by reducing the number of risk factors and treating comorbid conditions, including the currently most common liver disorder – non-alcoholic fatty liver disease. The article presents epidemiological data confirming the urgency of the problem, describes the common etiopathogenetic mechanisms of cardiovascular and liver diseases, justifies the use of known pharmaceuticals with pleiotropic effects, considering the principle of multipurpose monotherapy, which is using the systemic effects of one drug to correct the impaired functions of several organs or systems simultaneously.



Endovascular embolization in the treatment of patients with closed abdominal trauma
Abstract
Background. Closed abdominal trauma is often accompanied by damage to the abdominal organs and retroperitoneal space. With the development of medicine, minimally invasive methods of treating patients with bleeding due to closed abdominal trauma have become available, including endovascular embolization of the bloodstream, which allows one to avoid traditional operations (laparotomy) in this category of patients and achieve rapid rehabilitation of patients.
Aim. To evaluate the possibility of X-ray endovascular embolization in the treatment of patients with closed abdominal trauma.
Materials and methods. At the Sklifosovsky Research Institute of Emergency Medicine in 2022–2024 treated 68 patients with a diagnosis of “closed abdominal trauma”, of which 14 underwent direct angiography. In 4 (28.6%) patients, the intervention was diagnostic, in 10 (71.4%) it was therapeutic and diagnostic. These patients were included in this study: 8 (57.1%) men and 6 (42.9%) women.
Results. Selective embolization of the splenic artery was performed in four (28.5%) cases, the renal artery in 2 (14.2%), the lumbar artery in 2 (14.2%), and the hepatic artery in 2 (14.2%). A retroperitoneal (perinephric) hematoma was punctured percutaneously under ultrasound guidance in one case to exclude urinary leakage in a patient with a kidney injury. One (7.1%) patient required laparotomy due to recurrent bleeding. There were no complications from X-ray endovascular interventions. There were no cases of hematoma infection. One (7.1%) death in a 70-year-old patient with a closed abdominal injury, subcapsular hematoma of the spleen with comorbid pathology.
Conclusion. The use of X-ray endovascular embolization made it possible to avoid traditional surgical interventions (laparotomy) in 20.6% of cases. The introduction of X-ray endovascular hemostasis is one of the priorities in the treatment of patients with closed abdominal trauma.



Paraneoplastic limbic encephalitis in a patient with small cell lung cancer. Case report
Abstract
Paraneoplastic limbic encephalitis (PLE) is a rare autoimmune neurological syndrome caused by selective involvement of the limbic system with the development of neuropsychiatric symptoms and cognitive impairment. PLE is associated with malignancies. We observed PLE in a patient with small cell lung cancer (SCLC). Patient B. complained of severe weakness, headache attacks, irritability, memory loss, and cramps in the muscles of the limbs for 2 months. Contrast-enhanced magnetic resonance imaging of the brain showed signs of PLE. Anti-neuronal antibodies were detected in the blood serum: anti-Hu, anti-CV2 and anti-Ma2, anti-amphiphysin. In the cerebrospinal fluid, anti-Hu antibodies, lymphocytosis of 88%, and increased protein of 0.6 g/L were found. The patient was consulted by a neurologist and diagnosed with PLE. No treatment was administered. After 2 months, the patient reported a significant deterioration. Memory impairment progressed, convulsive seizures with short-term loss of consciousness became more frequent, and the patient became aggressive and withdrawn. Positron emission tomography combined with computed tomography with 18F-fluorodeoxyglucose was performed. There was an excessive radiopharmaceutical uptake in a limited area of the medial parts of the left temporal lobe. A tumor was detected in the upper lobe of the right lung. A bronchoscopy with biopsy was performed. Histological examination showed SCLC. Clinical diagnosis: SCLC of the right lung, stage IIb cT2bN1M0; PLE. Cytotoxic and immunotherapy were administered. The case shows that PLE is a rare neurological syndrome associated in most cases with SCLC, usually in the early stages of the malignancy. Neuropsychiatric and cognitive disorders and seizures are predominant in clinical presentation. PLE neuroimaging is performed using contrast-enhanced magnetic resonance imaging and positron emission tomography combined with computed tomography with 18F-fluorodeoxyglucose, the latter being the method of choice. The presence of antineuronal antibodies in serum and cerebrospinal fluid confirms the autoimmune (paraneoplastic) nature of the process.



An unusual case of respiratory failure in a patient with Randu–Osler–Weber disease. Case report
Abstract
Clinical observation is of interest due to the shift in the vector of the main complaints of the classic manifestation of Randu–Osler–Weber disease in the form of epistaxis and anemia syndrome towards the syndrome of severe respiratory failure, the cause of which is the presence of arteriovenous malformations in the lungs. The importance of an interdisciplinary approach to the diagnosis and treatment of patients with Randu–Osler–Weber disease is discussed.


